Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma

Cancer Research

Volumn 57, Issue 18, 1997, Pages 4057-4062

  Bell, Daphne W ^a   Jhanwar, Suresh C ^b   Testa, Joseph R ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CARCINOGENESIS; CHROMOSOME 6Q; CHROMOSOME LOSS; HUMAN; HUMAN CELL; MESOTHELIOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ALLELES; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 6; GENETIC MARKERS; HETEROZYGOTE; HUMANS; MESOTHELIOMA; MICROSATELLITE REPEATS;

EID: 0030850475     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Craighead, J. E., and Mossman, B. T. The pathogenesis of asbestos-associated diseases. N. Engl. J. Med., 306: 1446-1455, 1982.
2. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell. 61: 759-767, 1990.
3. Cavenee, W. K., Dryja, T. P., Phillips, R. A., Benedict, W. F., Godbout, R., Gallie, B. L., Murphree, A. L., Strong, L. C., and White, R. L. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature (Lond.), 305: 779-784, 1983.
4. Knudson, A. G., Jr. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res., 45: 1437-1443, 1985.
5. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995.
6. Hagemeijer, A., Versnel, M. A., Van Drunen, E., Moret, M., Bouts, M. J., van der Kwast, T. H., and Hoogsteden, H. C. Cytogenetic analysis of malignant mesothelioma. Cancer Genet. Cytogenet., 47: 1-28, 1990.
7. Popescu, N. C., Chahinian, A. P., and DiPaolo, J. A. Nonrandom chromosome alterations in human malignant mesothelioma. Cancer Res., 48: 142-147, 1988.
8. Tiainen, M., Tammilehto, L., Mattson, K., and Knuutila, S. Nonrandom chromosomal abnormalities in malignant pleural mesothelioma. Cancer Genet. Cytogenet., 33: 251-274, 1988.
9. Taguchi, T., Jhanwar, S. C., Siegfried, J. M., Keller, S. M., and Testa, J. R. Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. Cancer Res., 53: 4349-4355, 1993.
10. Meloni, A. M., Stephenson, C. F., Li, F. P., and Sandberg, A. A. del(6q) as a possible primary change in malignant mesothelioma. Cancer Genet. Cytogenet., 59: 57-61, 1992.
11. Millikin, D., Meese, E., Vogelstein, B., Witkowski, C., and Trent, J. Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res., 51: 5449-5453, 1991.
12. Walker, G. J., Palmer, J. M., Walters, M. K., Nancarrow, D. J., Parsons, P. G., and Hayward, N. K. Simple tandem repeat allelic deletions confirm the preferential loss of distal chromosome 6q in melanoma. Int. J. Cancer. 58: 203-206, 1994.
13. Offit, K., Parsa, N. Z., Gaidano, G., Filippa, D. A., Louie, D., Pan, D., Jhanwar, S. C., Dalla-Favera, R., and Chaganti, R. S. 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma. Blood, 82: 2157-2162, 1993.
14. Orphanos, V., McGown, G., Hey, Y., Boyle, J. M., and Santibanez-Koref, M. Proximal 6q, a region showing allele loss in primary breast cancer. Br. J. Cancer. 71: 290-293, 1995.
15. Devilee, P., van Vliet, M., van Sloun, P., Kuipers Dijkshoorn, N., Hermans, J., Pearson, P. L., and Cornelisse, C. J. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene, 6: 1705-1711, 1991.
16. Fujii, H., Zhou, W., and Gabrielson, E. Detection of frequent allelic loss of 6q23-q25.2 in microdissected human breast cancer tissues. Genes Chromosomes Cancer. 16: 35-39, 1996.
17. Sheng, Z. M., Marchetti, A., Buttitta, F., Champeme, M-H., Campani, D., Bistocchi, M., Lidereau, R., and Callahan, R. Multiple regions of chromosome 6q affecled by loss of heterozygosity in primary human breast carcinomas. Br. J. Cancer. 73: 144-147, 1996.
18. Theile, M., Seitz, S., Arnold, W., Jandrig, B., Frege, R., Schlag, P. M., Haensch, W., Guski, H., Winzer, K-J., Barrett, J. C., and Scherneck, S. A. A defined chromosome 6 fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer. Oncogene, 13: 677-685, 1996.
19. Orphanos, V., McGown, G., Hey, Y., Thorncroft, M., Santibanez-Koref, M., Russell, S. E. H., Hickey, I., Atkinson, R. J., and Boyle, J. M. Allelic imbalance of chromosome 6q in ovarian tumours. Br. J. Cancer, 71: 666-669, 1995.
20. Saito, S., Saito, H., Koi, S., Sagae, S., Kudo, R., Saito, J., Noda, K., and Nakamura, Y. Fine-scale deletion mapping of the distal long arm of chromosome 6 in 70 human ovarian cancers. Cancer Res., 52: 5815-5817, 1992.
21. Foulkes, W. D., Ragoussis, J., Stamp, G. W., Allan, G. J., and Trowsdale, J. Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br. J. Cancer, 67: 551-559, 1993.
22. Wan, M., Zweizig, S., D'Ablaing, G., Zheng, J., Velicescu, M., and Dubeau, L. Three distinct regions of chromosome 6 are targets of loss of heterozygosity in human ovarian carcinomas. Int. J. Oncol., 5: 1043-1048, 1994.
23. Merlo, A., Gabrielson, E., Mabry, M., Vollmer, R., Baylin, S. B., and Sidransky, D. Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer. Cancer Res., 54: 2322-2326, 1994.
24. Hirata, J., Abe, Y., Taguchi, F., Takaisuki, H., Nishimura, J., and Nawata, H. Deletion of chromosome 6q in two cases of acute myeloblastic leukemia and a review of the literature. Cancer Genet. Cytogenet., 58: 181-185, 1992.
25. Hayashi, Y., Raimondi, S. C., Look, A. T., Behm, F. G., Kitchingman, G. R., Pui, C. H., Rivera, G. K., and Williams, D. L. Abnormalities of the long arm of chromosome 6 in childhood acute lymphoblastic leukemia. Blood, 76: 1626-1630, 1990.
26. Antman, K. H., Li, F. P., Osteen, R., and Sugarbaker, D. J. Mesothelioma. In: S. DeVita, S. Hellman, and S. Rosenberg (eds.), Update: Cancer Principles and Practice, Vol. 3, pp. 1-16. Philadelphia: J. P. Lippincott, 1989.
27. Rodriguez, E., Rao, P. H., Ladanyi, M., Altorki, N., Albino, A. P., Kelsen, D. P., Jhanwar, S. C., and Chaganti, R. S. 11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomas. Cancer Res., 50: 6410-6416, 1990.
28. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, Ed. 2, pp. 9.16-9.19. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
29. Meloni, R., Fougerousse, F., Roudaut, C., and Beckmann, J. S. Dinucleotide repeat polymorphism at the human liver arginase gene (ARGI). Nucleic Acids Res., 20: 1166, 1992.
30. Dib, C., Faure, S., Fizames, C., Samaon, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Hazan, J., Seboun, E., Lathrop, M., Gyapay, G., Morrisette, J., and Weissenbach, J. A. Comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature (Lond.), 380: 152-154, 1996.
31. Morton, N. E., Collins, A., and Lawerence, S. Algorithms for a location database. Am. J. Hum. Genet., 56: 223-232, 1992.
32. Cooke, I. E., Cox, S. A., Shelling, A. N., Le Meuth, V. G., Spurr, N. K., and Ganesan, T. S. An integrated genetic map of chromosome 6. Mamm. Genome, 7: 157-159, 1996.
33. Cheng, J. Q., Jhanwar, S. C., Klein, W. M., Bell, D. W., Lee, W. C., Altomare, D. A., Nobori, T., Olopade, O. I., Buckler, A. J., and Testa, J. R. p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res., 54: 5547-5551, 1994.
34. Sekido, Y., Pass, H. I., Bader, S., Mew, D. J., Christman, M. F., Gazdar, A. F., and Minna, J. D. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res., 55: 1227-1231, 1995.
35. Bianchi, A. B., Mitsunaga, S. I., Cheng, J. Q., Klein, W. M., Jhanwar, S. C., Seizinger, B., Kley, N., Klein-Szanto, A. J. P., and Testa, J. R. High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc. Natl. Acad. Sci. USA, 92: 10854-10858, 1995.
36. Lee, W. C., Balsara, B., Liu, Z., Jhanwar, S. C., and Testa, J. R. Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma. Cancer Res., 56: 4297-4301, 1996.
37. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
38. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takahayashi, K., and Carson, D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368: 753-756, 1994.
39. Cooney, K. A., Wetzel, J. C., Consolino, C. M., and Wojno, K. J. Identification and characterization of proximal 6q deletions in prostate cancer. Cancer Res., 56: 4150-4153, 1996.
40. Sandhu, A. K., Kaur, G. P., Reddy, D. E., Rane, N. S., and Athwal, R. S. A gene on 6q14-21 restores senescence to immortal ovarian tumor cells. Oncogene, 12: 247-252, 1996.
41. Negrini, M., Sabbioni, S., Possati, L., Rattan, S., Corallini, A., Barbanti-Brodano, G., and Croce, C. M. Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosomes 6 and 11. Cancer Res., 54: 1331-1336, 1994.